https://mdpi-res.com/d_attachment/ebj/ebj-04-00024/article_deploy/ebj-04-00024.pdf?version=1687171751
"There is little benefit for the burn survivor if he or she hides at home and fears public exposure. The goal
should be to have all survivors return to work or school, redevelop intimate relationships,
and return to society. The goal of this paper is to provide basic strategies that optimize
healing outcomes in patients with any type of burn. While there are new products available,
excellent outcomes can be obtained with simple excision and autografting techniques."
"In the past, we used allograft, but currently, our allograft tends to degrade within a few weeks. Dermal substitutes seem
to last longer and may even slow down the hypermetabolic response. These products will
be covered by others, but we currently prefer “Novosorb BTM [Biodegradable Temporizing
Matrix]TM” (PolyNovo Biomaterials Pty Ltd., Victoria, Australia) as a temporary coverage"
The Clinicians Speak, page-515
-
- There are more pages in this discussion • 546 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.32 |
Change
-0.020(0.85%) |
Mkt cap ! $1.602B | |||
| Open | High | Low | Value | Volume |
| $2.35 | $2.37 | $2.30 | $2.354M | 1.012M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 11423 | $2.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.33 | 8018 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| PNV (ASX) Chart |